Beyond the Scale The benefits go further than pounds lost: Better blood sugar control Reduced risk of heart disease Decreased sleep apnea symptoms Improved mobility and quality of life The Challenges But the real results of GLP-1 in 2025 also include downsides: High cost (often $800$1200/month without insurance) Side effects (nausea, diarrhea, constipation, fatigue) Long-term dependence (weight often returns when stopping medication) Psychological adaptation (some users struggle with identity changes and food relationship shifts) GLP-1 Alone vs
This includes information such as age, BMI, no concurrent use of other medications from the GLP-1 class or other weight loss medications, and relevant past medical history
This finding laid the groundwork for decades of research (noted in the table below) exploring copper-peptide signaling and its potential biomedical and cosmetic applications
If you want to discuss which one would be best for you, we strongly encourage you to talk to us at Hormone Replacement Therapy LA

The complete side effect frequency breakdown from Phase 2 trials: Very Common (20%+ of patients at 12mg dose) Nausea: 28% Typically mild to moderate, peaks weeks 4-8, usually resolves by week 12 Diarrhea: 24% Usually transient (1-3 weeks), rarely severe Constipation: 21% Paradoxically coexists with diarrhea in different patients Common (10-20% of patients) Vomiting: 17% Decreased appetite: 16% (beyond therapeutic effect) Injection site reactions: 14% Fatigue: 13% Dyspepsia (indigestion): 12% Headache: 11% Uncommon (2-10% of patients) Abdominal pain: 8% Dizziness: 7% Gastroesophageal reflux: 6% Hypoglycemia in diabetics on other medications: 5% Increased heart rate (average 2-4 bpm): 4% Hair thinning/loss: 3% (typically temporary) Rare but Serious (Under 2%) Pancreatitis: 0.3% (3 cases out of 1,032 patients, all resolved with discontinuation) Gallbladder events: 1.4% (expected with rapid weight loss regardless of method) Acute kidney injury: 0.7% (all cases associated with severe dehydration) KEY TAKEAWAY: About 30% experience meaningful nausea in the first 4-8 weeks

Ozempic (semaglutide), originally a diabetes medication, is now widely prescribed for weight loss